Evidence map›Paper›PMID 30956970›Full record

ArticleData2019

Comparison of Micro-Census Results for Magarya Ward, Wurno Local Government Area of Sokoto State, Nigeria, with Other Sources of Denominator Data.

Margherita E Ghiselli, Idongesit Nta Wilson, Brian Kaplan, Ndadilnasiya Endie Waziri, Adamu Sule, Halimatu Bolatito Ayanleke, Faruk Namalam, Shehu Ahmad Tambuwal, Nuruddeen Aliyu, Umar Kadi and 8 more

Abstract read
In one paragraph

Article in Data, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Margherita E GhiselliU.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA; bkaplan@cdc.gov (B.K.); obb3@cdc.gov (O.B.).
Idongesit Nta WilsonNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Brian KaplanU.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA; bkaplan@cdc.gov (B.K.); obb3@cdc.gov (O.B.).
Ndadilnasiya Endie WaziriNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Adamu SuleNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Halimatu Bolatito AyanlekeNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Faruk NamalamSokoto State Emergency Routine Immunization Coordination Center (SERICC), Sokoto Town, Sokoto State 840212, Nigeria; namalamf@gmail.com.
Shehu Ahmad TambuwalSokoto State Primary Health Care Development Agency (SPHCDA), Sokoto Town, Sokoto State 840212, Nigeria; Shehuat66@gmail.com.
Nuruddeen AliyuNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Umar KadiNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Omotayo BoluU.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA; bkaplan@cdc.gov (B.K.); obb3@cdc.gov (O.B.).
Nyampa BarauNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Mohammed YahayaNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Gideon UgbenyoNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Ugochukwu OsigweNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Clara OgujiNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Nnamdi UsifohNational Stop Transmission of Polio (NSTOP), Asokoro, Abuja 900231, Nigeria; winidongesit@live.com (I.N.W.); ewaziri@afenet.net (N.E.W.); asule@afenet.net (A.S.); hayanleke@afenet.net (H.B.A.); naliyu@afenet.net (N.A.); umarkadi247@gmail.com (U.K.); dr.barau@gmail.com (N.B.); yahyakt@yahoo.com (M.Y.); ug.gideon@gmail.com (G.U.); uosigwe@afenet.net (U.O.); claraoguji@gmail.com (C.O.); maxiusifoh@gmail.com (N.U.).
Vincent SeamanBill and Melinda Gates Foundation, Seattle, WA 98109, USA; vincent.seaman@gatesfoundation.org.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Routine immunization coverage in Nigeria is suboptimal. In the northwestern state of Sokoto, an independent population-based survey for 2016 found immunization coverage with the third dose of Pentavalent vaccine to be 3%, whereas administrative coverage in 2016 was reported to be 69%. One possibility driving this large discrepancy is that administrative coverage is calculated using an under-estimated target population. Official population projections from the 2006 Census are based on state-specific standard population growth rates. Immunization target population estimates from other sources have not been independently validated. We conducted a micro-census in Magarya ward, Wurno Local Government Area of Sokoto state to obtain an accurate count of the total population living in the ward, and to compare these results with other sources of denominator data. We developed a precise micro-plan using satellite imagery, and used the navigation tool EpiSample v1 in the field to guide teams to each building, without duplications or omissions. The particular characteristics of the selected ward underscore the importance of using standardized shape files to draw precise boundaries for enumeration micro-plans. While the use of this methodology did not resolve the discrepancy between independent and administrative vaccination coverage rates, a simplified application can better define the target population for routine immunization services and estimate the number of children still unprotected from vaccine-preventable diseases.

Indexed as

censusimmunizationNigeriatarget population

Identifiers

PMID30956970
PMCPMC6444184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.